We lead the way in strategic consulting in the AMNOG context.
How to ideally emphasize the benefits of your product for the German market? Which price strategy is feasible and financially promising? How do you make optimal use of the oral hearing procedure? What does an efficient price negotiation look like? Let us join forces and answer these critical questions. Together we can achieve results for your sustainable competitive success.
We develop a Germany-specific value story from the global value message in order to succeed. With an experienced outside perspective we support you in the orchestration of the internal stakeholders – the cooperation of various disciplines such as Legal, Regulatory and Medical Affairs is crucial to extract the value of enduring research.
For our clients in the pharmaceutical industry, we use our extensive care and industry knowledge, our medical know-how as well as the experience gained from the many projects which we have assisted in the benefit assessment according to AMNOG.
We are familiar with the external decision makers and multipliers, so that we can extract the relevant arguments from the value story for each target group.
Numerous projects have taught us to understand the statutory health insurance and in return we can adopt their position. We ensure that the existing arguments undergo a stress test in advance to the negotiation in order for you to be prepared for the other side’s potential argumentative position in the best way possible.
Our portfolio of operations ranges from the development of practical and strategic competencies for these undertakings, the coaching and strategic sparring to taking over operational responsibility throughout the negotiation. We are familiar with the needs of your contractual partner, know how to fulfill the expectations of the German market, and to beneficially deploy reciprocal dependencies in multinational context for you.
- Alexion Pharmaceuticals
- Astellas Pharma
- Bayer Vital
- Berlin Chemie
- Bristol Myers Squibb
- Destin Arzneimittel
- Laboratoires C.T.R.S.
- Roche Pharma
- Shionogi & Co.
- Shire Deutschland
- United Therapeutics
- UCB Germany
- Verband forschender Arzneimittelhersteller
Prof. Matthias P. Schönermark, M.D., Ph.D.